- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03078283
Food Effects on the Gut Microbiota
January 21, 2020 updated by: Jeffrey I. Gordon, Washington University School of Medicine
Effects of High-fiber Snack Foods on Human Gut Microbes
This is a small-scale study of the effects on microbes in the human gut of adding high-fiber snack foods to usual diet.
The snack foods are being provided by Mondelez International, Inc.
Eight pairs of dizygotic twins, discordant or concordant for obesity, will participate in the study.
They will complete 3 successive experiments in which their regular diet is supplemented by consumption, over a 6-week period, of high-fiber snack foods.
Each experiment will involve (i) two weeks consuming regular diet (fecal sample collected weekly); (ii) one week consuming one snack food per day (approximately 7 g fiber, collection of all fecal samples), (iii) one week consuming two snack foods per day (approximately 14 g fiber, collection of all fecal samples), (iv) four weeks consuming three snack foods per day (approximately 20 g fiber, collection of all fecal samples); and (v) two weeks consuming only regular diet (weekly collection of fecal sample).
For each experiment, participants will also provide a fasting blood sample during the free diet phase at the end of the week just before initiation of snack consumption, and a fasting blood sample at the end of the last week of snack consumption.
Participants will also collect one first morning urine sample weekly throughout the study.
During week 2, participants will also collect first morning urine samples for 3 consecutive days.
Similarly, they will collect first morning urine samples for the last 3 consecutive days of the last week of snack consumption.
The study will test the effects of the different fiber-rich snacks on the composition and metabolic properties of the gut microbial community in lean and obese subjects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
31 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
* member of female dizygotic twin pair discordant or concordant for obesity
Exclusion Criteria:
- pregnant or trying to get pregnant
- inflammatory bowel disease
- gastrointestinal cancer
- hepatitis
- HIV
- renal failure
- food allergies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Participants
Consumption of a given type of high-fiber snack food, with each individual functioning as her own control
|
In 3 successive experiments, usual diet will be supplemented with snack foods containing fiber of plant, fruit or grain origin.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of gut microbial community structure and function
Time Frame: 8 weeks
|
Sequencing bacterial 16S rRNA amplicons plus shotgun sequencing of fecal community DNA to identify effects of fiber-enriched foods on bacterial community and gene representation; mass spectrometry of products of gut microbial community metabolism.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jeffrey I Gordon, MD, Washington University School of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 10, 2017
Primary Completion (Actual)
December 31, 2018
Study Completion (Actual)
September 30, 2019
Study Registration Dates
First Submitted
March 8, 2017
First Submitted That Met QC Criteria
March 8, 2017
First Posted (Actual)
March 13, 2017
Study Record Updates
Last Update Posted (Actual)
January 22, 2020
Last Update Submitted That Met QC Criteria
January 21, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- MDLZ2017JIG1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Individual data will be shared after completion of the study, to the extent that this can be accomplished without violating the confidentiality of participants (some of whom would be easily identifiable from their clinical metadata).
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on high-fiber food type
-
University of CopenhagenDanish Meat Research InstituteCompleted
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Coordenação de Aperfeiçoamento de...CompletedDiabetes Mellitus Type 2 | Dietary Modification | Insulin Tolerance | Diabetic Blood Glucose MonitoringBrazil
-
Washington University School of MedicineCompletedMicrobiota | Gastrointestinal MicrobiomeUnited States
-
Stoffwechselzentrum Rhein - PfalzGlucanova ABCompletedObesity | Diabetes Mellitus, Type 2 | Overweight | Metabolic SyndromeGermany
-
Purdue UniversityCompletedObesity | Dietary Modification | Lack of Satiety | Memory DeficitsUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Wageningen University and ResearchJ. Rettenmaier & Sohne GmbH & Co. KGCompleted
-
University of Texas Southwestern Medical CenterCompletedNon-Insulin-Dependent Diabetes Mellitus
-
University of Missouri-ColumbiaRecruiting